Nagendran Sukumar - Insider Non-Derivative Transactions at Taysha Gene Therapies, Inc. (TSHA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 2, 2024, Nagendran Sukumar's relationship to Taysha Gene Therapies, Inc. (TSHA) is Director,Officer (President and Head of R&D), and currently has 897,843 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TSHA insiders.
Data Source: SEC.
Nagendran Sukumar - Insider Non-Derivative Transactions of TSHA Common Stock
Nagendran Sukumar - Insider Non-Derivative Transactions at TSHA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 3, 2024 | Acquisition -- (Common Stock) | 863617 | 0 | 897843 |
| May 17, 2023 | P -- (Common Stock) | 5000 | 0.68 | 34226 |